Cargando…

Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study

PURPOSE: Our study aims to analyze the association between HER2 status of breast cancer (BC) and second primary malignancy (SPM) occurrence. MATERIALS AND METHODS: Based on BC patients registered between 2010 and 2018 in the NCI SEER database, we utilized standardized incidence ratio (SIR) and Poiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiaoyi, Lin, Xin, Li, Yingzi, Zhang, Yuchen, Lin, Jiali, Zhang, Guochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627860/ https://www.ncbi.nlm.nih.gov/pubmed/34853531 http://dx.doi.org/10.2147/IJGM.S338455

Ejemplares similares

Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Risk of contralateral second primary breast cancer according to hormone receptor status in Germany
por: Rusner, Carsten, et al.
Publicado: (2014)

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
por: Liou, Miaw-Jene, et al.
Publicado: (2016)

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015)

Pattern of occurrence and treatment outcome of second primary malignancies: A single center experience
por: Chaudhary, Prekshi, et al.
Publicado: (2017)

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
por: Lee, Yu-Ting, et al.
Publicado: (2015)

Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report
por: Pirozzi, Angelo, et al.
Publicado: (2019)

Co-Occurrence of Differentiated Thyroid Cancer and Second Primary Malignancy: Correlation with Expression Profiles of Mismatch Repair Protein and Cell Cycle Regulators
por: Liu, Chih-Yi, et al.
Publicado: (2021)

Incidence of second primary malignancies in women with different stages of breast cancer
por: Lin, Cheng-Yao, et al.
Publicado: (2023)

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
por: Li, Kai, et al.
Publicado: (2020)

Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer
por: James, Rani, et al.
Publicado: (2011)

Metastatic Breast Cancer Survival according to HER2 and Topo2a Gene Status
por: Todorović-Raković, N., et al.
Publicado: (2009)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Association of Body Mass Index With Somatic Mutations in Breast Cancer
por: Chen, Bo, et al.
Publicado: (2021)

Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status
por: Kai, Keita, et al.
Publicado: (2012)

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours
por: Chen, Bo, et al.
Publicado: (2021)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis
por: Hu, Tulan, et al.
Publicado: (2021)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

Second primary malignancies in patients with male breast cancer
por: Hemminki, K, et al.
Publicado: (2005)

Correlation between lymphoma and second primary malignant tumor
por: Liu, Lingjuan, et al.
Publicado: (2023)

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients
por: Wen, Lingzhu, et al.
Publicado: (2021)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

Prognostic significance of the expression of HER family members in primary osteosarcoma
por: Wang, Sheng-Lin, et al.
Publicado: (2018)

Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status
por: Mao, Kai, et al.
Publicado: (2017)

Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
por: Al-Qahtani, Khalid H., et al.
Publicado: (2015)

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions
por: Kim, Hongsik, et al.
Publicado: (2019)

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status
por: Zhang, Guochun, et al.
Publicado: (2022)

Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
por: Shi, Hong-Zhi, et al.
Publicado: (2017)

Analysis and prediction of second primary malignancy in patients with breast cancer
por: Long, Quanyi, et al.
Publicado: (2022)

Unusual occurrence of accessory central cusp in the maxillary second primary molar
por: Nirmala, S.V.S.G, et al.
Publicado: (2011)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors
por: Palm, Christiane, et al.
Publicado: (2023)

Second primary malignancies in thyroid cancer patients
por: Rubino, C, et al.
Publicado: (2003)

Second primary malignancies among cancer patients
por: Zheng, Xuanqi, et al.
Publicado: (2020)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis
por: Huang, Haowei, et al.
Publicado: (2023)

Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
por: Tsakountakis, Nikos, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_a2s9p3dbs0k5oj1m1phpfugdin